IL13 and chronic obstructive pulmonary disease: In this context, IL-13 warrants further investigation, particularly when considered alongside other T2 markers such as blood eosinophils and FeNO, to enhance the differentiation of ACO from COPD and to support a treatable-trait-based management approach.